Stock comparison
Align Technology
IDEXX Laboratories
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
ALGN
Align Technology
Market cap
$11.71B
Sector
Healthcare
IDXX
IDEXX Laboratories
Market cap
$43.67B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | ALGN | IDXX | Winner |
|---|---|---|---|
| Warren Buffett | 56C | 75B | IDXX |
| Benjamin Graham | 66B | 80A | IDXX |
| Philip Fisher | 40D | 75B | IDXX |
| Peter Lynch | 18F | 71B | IDXX |
| Joel Greenblatt | 36D | 83C | IDXX |
| Charlie Munger | 42D | 87A | IDXX |
| Terry Smith | 44D | 84A | IDXX |
Side-by-side metrics
| Metric | ALGN | IDXX |
|---|---|---|
| Market cap | $11.71B | $43.67B |
| P/E (TTM) | 26.1x | 39.0x |
| EV/EBIT | 16.7x | 31.6x |
| ROIC (TTM) | 9.72% | 40.66% |
| Gross margin | 67.68% | 62.05% |
| Net margin | 10.5% | 24.63% |
| Revenue CAGR 5y | 0.52% | 7.56% |
| EPS CAGR 5y | -12.78% | 10.79% |
| Debt / Equity | 0.0x | 0.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
ALGN leads on
- Debt / Equity0.0xvs 0.7x+97%
- EV/EBIT16.7xvs 31.6x+47%
- P/E (TTM)26.1xvs 39.0x+33%
- Gross margin67.68%vs 62.05%+8%
IDXX leads on
- EPS CAGR 5y10.79%vs -12.78%+184%
- Revenue CAGR 5y7.56%vs 0.52%+93%
- ROIC (TTM)40.66%vs 9.72%+76%
- Market cap$43.67Bvs $11.71B+73%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.